Manufacturer record
Himalaya Meditek Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
36 batches manufactured by Himalaya Meditek Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between February 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: HLI992M, Promethazine Injection I.P. (exp Nov 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. with respect to the Tests of pH and Assay. Listed in the September 2026 alert.
Records by type
36 records linked to Himalaya Meditek Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
36Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
36
NSQ batches since 2019
26
Products affected
Assay
Most common failure
Sep 2026
Latest alert
Flagged batches per year
2019 · 32020 · 22021 · 22022 · 22024 · 92025 · 92026 · 9
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Promethazine Injection I.P. | Batch HLI992MMfg Dec 2025 · Exp Nov 2027 | The sample does not conform to I.P. with respect to the Tests of pH and Assay.Assay | CDL, KolkataCDSCO lab | Sep 2026 |
| Ceftriaxone Injection IP 1.0 gm | Batch HD1304EMfg May 2025 · Exp Apr 2027 | The sample does not conforms to I.P. in respect of Particulate matterParticulate matter | Gorakhpur, Uttar PradeshState lab | Sep 2026 |
| Promethazine Injection I.P. 2ml | Batch HLI992MMfg Dec 2026 · Exp Nov 2027 | The sample does not conform to I.P with respect to test for 'Particulate matter' and is also not of standard quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Jul 2026 |
| Betamethasone Sodium Phosphate Injection I.P. | Batch HL11006MMfg Dec 2025 · Exp Nov 2027 | The sample does not conforms to the IP with respect to Description, Particulate Matter and Assay.Assay | DTL JaipurState lab | Jul 2026 |
| Hyoscine Butylbromide Injection IP | Batch HLI591HMfg Aug 2025 · Exp Jul 2028 | The sample does not conform to claim as per IP 2022 in respect to the Test of Particulate matter.Particulate matter | RDTL, ChandigarhCDSCO lab | Apr 2026 |
| Risperidone Tablets IP 4mg | Batch HTN172GMfg Jul 2025 · Exp Jun 2027 | The sample fails the test 'Dissolution' as per IPDissolution | DTL ThiruvananthapuramState lab | Mar 2026 |
| Promethazine Injection IP | Batch HLI511GMfg Jul 2025 · Exp Jun 2027 | The sample does not conform to I.P. with respect to test for pH, Particulate matter, Extractable volume, Assay of Promethazine Hydrochloride and Description.Assay | CDL, KolkataCDSCO lab | Feb 2026 |
| Omeprazole Capsules IP 20mg | Batch HCN460GMfg Jul 2024 · Exp Jun 2026 | Dissolution.Dissolution | DTL, Chennai-06State lab | Feb 2026 |
| Atorvastatin Calcium Tablets IP 10mg | Batch HTN792GMfg Jul 2024 · Exp Jun 2026 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Dexamethasone Sodium Phosphate Injection I.P (Dexasun-For IM & IV use only) | Batch HLI380CMfg Mar 2024 · Exp Feb 2026 | Sterility and Assay for Dexamethasone PhosphateAssay | State Lab KarnatakaState lab | Jun 2025 |
| Ranitidine Injection IP-2ML | Batch HLI352CMfg Mar 2024 · Exp Feb 2026 | Sample does not conform to requirement for AssayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | May 2025 |
| Gentamicin Injection I.P-2ml | Batch HLI624FMfg Jun 2024 · Exp May 2025 | Sample does not conform to the requirement for pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | May 2025 |
| Omeprazole Capsules IP 20mg | Batch HCN423FMfg Jun 2024 · Exp May 2026 | Sample does not conform to IP specification with respect to Uniformity of weightUniformity of weight/content | DTL MaduraiState lab | Apr 2025 |
| Cefixime Tablets IP 400 mg | Batch HTB404GMfg Jul 2024 · Exp Jun 2026 | Sample does not conform to IP Specification for Cefixime Tablets with respect to the content of Anhydrous Cefixime in Cefixime Trihydrate.Other | DTL MaduraiState lab | Apr 2025 |
| Gentamicin Injection IP- 2ml | Batch HLI615FMfg Jun 2024 · Exp May 2026 | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab | Jan 2025 |
| Gentamicin Injection IP- 2ml | Batch HLI623FMfg Jun 2024 · Exp May 2026 | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab | Jan 2025 |
| Gentamicin Injection IP- 2ml | Batch HLI628FMfg Jun 2024 · Exp May 2026 | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab | Jan 2025 |
| Gentamicin Injection IP- 2ml | Batch HLI620FMfg Jun 2024 · Exp May 2026 | sample does not Conform to the requirement for PHpH | King Institute ChennaiState lab | Jan 2025 |
| Metoclopramide HCL Injection I.P-2ml | Batch HLI405DMfg Apr 2024 · Exp Mar 2026 | sample does not conform to the requirement for Assay of MetoclopramideAssay | King Institute ChennaiState lab | Dec 2024 |
| Ciprofloxacin Hydrochloride Tablets IP 500mg | Batch HTN1126LMfg Nov 2023 · Exp Oct 2025 | Sample does not conform to IP specification for ciprofloxacin tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Dec 2024 |
| Atorvastatin Calcium Tablets IP 10mg | Batch HTN414DMfg Apr 2024 · Exp Mar 2026 | Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Dec 2024 |
| Atorvastatin Calcium Tablets IP 10mg | Batch HTN405DMfg Apr 2024 · Exp Mar 2026 | Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Dec 2024 |
| Atorvastatin Calcium Tablets IP 10mg | Batch HTN906JMfg Sep 2023 · Exp Aug 2025 | Sample does not conform to IP Specification for Atorvastatin Calcium Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Nov 2024 |
| Panlib -D [Pantoprazole and Domeperidone Tablets] | Batch HTN253DMfg Apr 2024 · Exp Mar 2026 | It fails the test ?Disintegration? as per IP and the contents of active ingredients of Pantoprazole and Domeperidone are not with in the limits of ?Schedule V? of Drugs and Cosmetics Act & Rules thereunder as specified in the Laboratory ProtocolDisintegration | DTL ThiruvananthapuramState lab | Oct 2024 |
| Wintel 40 Tablets | Batch HTN257DMfg Apr 2024 · Exp Mar 2026 | It fails the test ?Dissolution? as per IPDissolution | DTL ThiruvananthapuramState lab | Sep 2024 |
| Panlib 40 Tablets | Batch HTN 102AMfg Jan 2024 · Exp Dec 2025 | It fails the test Dissolution? and ?Assay? as per IPAssay | DTL ThiruvananthapuramState lab | Sep 2024 |
| Ceftriaxone Injection IP 250 mg (JKMSCL Hospital Supply) | Batch HD1607FMfg Jun 2023 · Exp May 2025 | The sample fails in Uniformaity of weights & Assay/Contents are found less than the label claimAssay | State Drugs Testing Laboratory Srinagar (Jammu & Kashmir)State lab | Apr 2024 |
| CLARIFORD-500 (Clarithromycin Tablets IP 500 mg) | Batch HTN303CMfg Mar 2020 · Exp Feb 2023 | Dissolution and AssayAssay | CDTL MumbaiCDSCO lab | Oct 2022 |
| Dicyclomine Hydrochloride Injection I.P. 2 ml | Batch HLI471DMfg Apr 2021 · Exp Mar 2023 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Mar 2022 |
| Zolam 0.25 (Alprazolam Tablets I.P. 0.25 mg) | Batch HLI282BMfg Feb 2020 · Exp Jan 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Sep 2021 |
| Hydrocortisone Sodium Succinate Injection I.P. | Batch HDI121AMfg Jan 2020 · Exp Dec 2021 | Clarity of Solution, Particulate matter, Assay of HydrocortisoneAssay | CDL KolkataCDSCO lab | Aug 2021 |
| Cipjohn 500 (Ciprofloxacin Tablets I.P. 500 mg) | Batch HTN813DMfg Apr 2018 · Exp Mar 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | May 2020 |
| Metoclopramide Inj. USP 10MG/2ML | Batch HLI933AMfg Jan 2019 · Exp Dec 2020 | Organic impurities and AssayAssay | RDTL ChandigarhCDSCO lab | Apr 2020 |
| Ciprofloxacin Tablets I.P. 500mg. (Cipjohn- 500) | Batch HTN813DMfg Apr 2018 · Exp Mar 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2019 |
| (RANITIDINE INJECTION IP) | Batch HLI849KMfg Oct 2018 · Exp Sep 2020 | Particulate MatterParticulate matter | RDTL ChandigarhCDSCO lab | Aug 2019 |
| Amoxycillin Capsules IP (Amoxytor-250) | Batch HCB709LMfg Nov 2017 · Exp Oct 2020 | AssayAssay | Drugs Control Department, Arunachal PradeshCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.